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Abstract
New endoscopic techniques for hemostasis in nonva-
riceal bleeding were introduced and known methods 
further improved. Hemospray and Endoclot are two 
new compounds for topical treatment of bleeding. Initial 
studies in this area have shown a good hemostatic 
effect, especially in active large scale oozing bleeding, 
e.g. , tumor bleedings. For further evaluation larger 
prospective studies comparing the substanced with 
other methods of endoscopic hemostasis are needed. 
For localized active arterial bleeding primary injection 
therapy in the area of  bleeding as well as in the four 
adjacent quadrants offers a good method to reduce 
bleeding activity. The injection is technically easy to 
learn and practicable. After bleeding activity is reduced 
the bleeding source can be localized more clearly for 
clip application. Today many different through-the-
scope (TTS) clips are available. The ability to close and 
reopen a clip can aid towards good positioning at the 
bleeding site. Even more important is the rotatability of 
a clip before application. Often multiple TTS clips are 
required for secure closure of a bleeding vessel. One 
model has the ability to use three clips in series without 
changing the applicator. Severe arterial bleeding from 
vessels larger than 2 mm is often unmanageable with 
these conventional methods. Here is the over-the-scope-
clip system another newly available method. It is similar 
to the ligation of esophageal varices and involves aspi-
ration of tissue into a transparent cap before closure 
of the clip. Thus a greater vascular occlusion pressure 
can be achieved and larger vessels can be treated 
endoscopically. Patients with severe arterial bleeding 
from the upper gastrointestinal tract have a very high 
rate of recurrence after initial endoscopic treatment. 
These patients should always be managed in an 
interdisciplinary team of interventional radiologist and 
surgeons.
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with nonvariceal hemorrhage present with an anticoagu-
lative or antithrombotic medication. Often the patient 
suffers from concomitant disease. In the recent years 
new methods for flexible endoscopic treatment of 
hemorrhage have been developed. The following article 
discusses the current literature of the new endoscopic 
methods in the context of every day practice in endos-
copic treatment for nonvariceal hemorrhage.  
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INTRODUCTION
Endoscopic hemostatic treatment is the gold standard 
for active gastrointestinal bleeding, as well as for 
recent bleeding with stigmata of a high recurrence 
rate. International treatment guidelines recommend 
an early risk stratification by immediate endoscopic 
diagnosis and treatment[1]. Injection therapy, clip appli­
cation and thermal hemostasis are well established 
methods of mono therapies. However a combination 
of two hemostatic methods have been found to be 
superior to an individual method alone and should 
therefore be preferred[2]. Mechanical hemostasis with 
clips can be limited due to poor angulation and mobility 
of the endoscope, e.g., in the duodenal bulb. Also some 
conventional clips cannot be reopened after closing 
even after poor placement.
In this review we highlight recent innovations in the 
field of endoscopic hemostasis in nonvariceal bleeding 
in the upper gastrointestinal tract with a focus on new 
topically applied substances (e.g., Ankafer, Hemospray 
and EndoClot) and newly developed clips [instinct clip 
and over­the­scope­clip (OTSC)]. 
Before endoscopic treatment of a nonvariceal bleeding 
certain factors that correlate with a high rate of re­
bleeding, should be considered. Interdisciplinary solu­
tions should be evaluated at an early stage. Ogasawara 
et al[3] described in a single center retrospective study 
the parameters: Age > 70 years, hemorrhagic shock on 
admission, hemoglobin < 8 mg/dL, serum albumin < 3.3 
g/dL, vessels > 2 mm and Forrest Ⅰa and Ⅰb ulcers as 
negative predictors. The strongest predictors of failure 
of endoscopic therapy is a vessel diameter > 2 mm 
(OR = 4:38; 95%CI: 1.25­7.01) and the presence of 
hemorrhagic shock (OR = 5.26, 95%CI: 2.43­11.6)[3].
The authors describe precisely the approach when 
initial hemostasis fails. From 2000­2010, n = 428 
patients were treated with Forrest Ⅰa/Ⅰb (FⅠa/FⅠ
b) and Forrest Ⅱa/b (FⅡa/FⅡb) lesions. The authors 
describe a standardized second­look endoscopy after 
24 h in all patients. A recurrent bleeding occurred in 
69 (16%) of the patients. Twelve percent of those 
received surgery, 4% died. For the entire population of 
428 patients with FⅠa/FⅠb and FⅡa/FⅡb bleeding 
endoscopic failure rate of 17/428 (4%).
The second endoscopic hemostasis was successful 
in 46/69 (66.7%). A third intervention was successful 
in 11/23 (47.8%) of the patients. With this approach, 
the authors were able to treat 57/69 (82%) recurrences 
during follow­up.
This work shows that by endoscopic hemostasis 
a large proportion of patients with upper nonvariceal 
gastrointestinal bleeding can be permanently treated 
with the first endoscopic hemostasis.
Attention should be paid to the special situation of a 
large visible vessel (> 2 mm). Especially arterial vessels 
on the posterior wall of the duodenal bulb should gain 
attention. Surprisingly, the proportion of intractable 
bleeding in the study of Ogasawara et al[3] were more 
frequent in the duodenal bulb, but this did not reach 
statistical significance.
Another crucial parameter before starting any 
endoscopic therapy in the presence of bleeding is the 
fact that especially non­bleeding­related comorbidities 
cause the mortality of non variceal bleeding[4]. The 
number of comorbidities and the probably of taking 
anticoagulative or antithrombotic drugs will affect 
decisively the prognosis in the individual cases.
NEW HEMOSTASIS METHODS - 
TOPICALLY APPLIED SUBSTANCES
Surface bleeding provides a problem for common hemo­
static methods. Injections work better with localized 
active bleeding sources. Also, after injection of NaCl 
or diluted epinephrine solution a decongestion of the 
injected volume cause a reactivation of bleeding. 
Mechanical hemostatic methods can cannot easily be 
used for diffuse mucosal bleeding. Hemostasis with 
argon plasma coagulation would be the method of 
choice but a High Frequency (HF) Generator is required, 
which must be frequently initially activated in emergency 
examinations or on the intensive care unit.
Over the past 50 years, various substances for topical 
hemostasis were developed especially in open surgery. 
Bergel in 1909 described the application of fibrin to 
accelerate hemostasis. Other locally applied substances 
include thrombin clotting factors and sucralfate, which 
have been described with differing results in small case 
series[5].
Currently the literature describes three substances, 
used for endoscopic hemostasis (Table 1). Hemospray 
(Cook Medical, Limerik, Ireland) and EndoClot (EPI, 
Santa Clara CA, United States) are eligible for endoscopic 
treatment of nonvariceal bleeding. The preparation of 
ankaferd [ankaferd blood stopper (ABS)] is not available 
for endoscopic hemostasis in Germany. 
ABS
ABS is a preparation of Turkish medicine, specified by 
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the manufacturer as a blend of vegetable ingredients. 
A preparation of 100 mL of ABS is composed of a 
standardized mixture of plants, including 5 mg Thymus 
vulgaris (dried grass extract), 9 mg Glycyrrhiza glaba 
(dried leaf extract), 8 mg Vitis vinifera (dried leaf 
extract), 7 mg Alpinia officinarum (dried leaf extract), 
and 6 mg Urtica dioica (dried root extract)[6].
The endoscopic application of ABS is published in 
case reports and series for treatment of Mallory­Weiss 
tears, Dieulafoy ulcers, GAVE, anastomotic bleeding, 
post sphincterotomy and tumor bleeding[7]. Prospective 
randomized trials compairing ABS to other endoscopic 
hemostasis procedures are lacking.
HEMOSPRAY TC-325
Hemospray (also named TC­325) is a mineral­based 
powder from Cook Medical Limerick Irland. It was 
developed by the armed forces for control of bleeding 
in military operations. The powder is applied via a CO2 
pressurized handle. The powder is sprayed onto the 
source of bleeding and it is important for the application 
that an active bleeding is present. Only then the effect 
of the substance can occur.
In an animal model with an artificial arterial bleeding 
in the stomach, endoscopic hemostasis could successfully 
be achieved[8]. There was no evidence for an embolic 
removal of the substance into the circulatory system 
or local reactions at the site of bleeding. Sung et al[9] 
reported 2011 on the first application of hemostasis for 
n = 20 patients with peptic ulcer bleeding. The acute 
hemostasis rate was 95% (19/20). One patient with 
a FⅠa hemorrhage had to be embolized radiologically 
due to a pseudoaneurysm. Out of the patients with 
a successful initial treatment, 2/10 (11%) showed a 
recurrence of bleeding within 72 h, however these could 
again be treated endoscopically[9].
In 2013, the results of the “Evaluate Survey of 
the Application of Hemospray in the luminal tract”, a 
European database, were published[10]. The authors 
report on n = 30 patients with peptic ulcers and n = 
33 patients with other nonvariceal bleeding sources 
(e.g., post EMR, tumor bleeding, Dieulafouy ulcer). 
Monotherapy with Hemospray was carried out in 87%. 
The primary hemostasis rate was 85%. A rebleeding 
within 7 d occurred in 15% of all treated patients. In 8 
cases Hemospray was applied adjuvantly after ineffective 
primary hemostasis with other methods. In all eight cases, 
treatment with Hemospray was successful, however, 
rebleeding occurred in 25%.
Another typical indication for Hemospray are large 
diffuse tumor bleedings. Chen et al[11] described the 
successful treatment of n = 5 patients with different 
tumor bleedings. Binkau et al[12] successfully treated 
two cases of an ulcerated carcinoma of the stomach 
and one case of small cell lung cancer, with bleeding 
from a metastasis in the stomach. The advantage 
of Hemospray is the contact­free application of the 
substance to a diffusely bleeding tumor surface. Upon 
blood contact, local hemostasis is accelerated (Figure 1). 
ENDOCLOT
EndoClot contains absorbable polysaccharide particles, 
which are polysaccharides that absorb the blood fluid 
and form a gel to accelerate coagulation.
The substance is applied over a catheter with an air 
compressor. During application, the catheter tip has to 
be held at a distance from the bleeding source in order 
to prevent blockage of the catheter. 
Müller­Gerbes et al[13] report their experience of 
treating 22 patients either with EndoClot alone (17 
patients) or in combination with other hemostatic me­
thods (5 patients). Overall, hemostasis was successful 
in 21/22 patients. Out of these cases 8 involved diffuse 
tumor bleeding which could be stopped.
However, Holster et al[14] could report sufficient 
hemostasis in patients with active arterial bleeding who 
were under anticoagulants. 
Overall topically applied substances are particularly 
helpful for diffuse bleedings with low activity and 
without a clearly localized source. Also, patients taking 
anticoagulants or antithrombotic medication can well 
be treated with the new substances. Other indications 
such as arterial bleeding have shown less favorable 
results. In order to more firmly establish topically applied 
substances in the algorithm of endoscopic hemostatic 
therapy, larger studies comparing them to conventional 
methods are at need. 
If positioning of the endsocope is adequate and 
the endoscopic team is clip­experienced, a mechanical 
method for hemostasis could be preferred. For this 
Contains Mechanism of action Approved human application Formulation
Ankaferd blood stopper Herbal mixture Forms protein networks, activates clotting 
cascade
Dental procedures, first aid 
services
Tampons, sprays, ampoules
Hemospray Mineral powder Absorbs H2O, mechanical tamponade, 
activates clotting cascade




Absorbs H2O and concentrate cells, 
activates clotting cascade
Adjuvant hemostatic therapy Pressurized air compressor
Table 1  Overview on the commercially available substanced for topical application[5] 
GI: Gastrointestinal.
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modality new clip models were presented in recent 
years.
CLIPS FOR MECHANICAL ENDOSCOPIC 
HEMOSTASIS
There are two groups of clips: Clips applied through 
the working channel of an endoscope [Through­the­
Scope (TTS)] and clips pre­loaded with a transparent 
detachable cap at the distal end of the endoscope (over 
the scope OTSC) (Figure 2).
The TTS clips are available from different manu­
facturers and with different opening lengths (Table 2, 
Figures 3 and 4). A clip with three branches (TriClip, 
Cook Medical, Ireland) is now no longer available. Pro­
spective studies with the TriClip compared to the Quick 
Clip (Olympus, Hamburg, Germany) showed a slightly 
worse outcome for the TriClip. Another study showed 
more recurrent bleeding with the TriClip (15% vs 29%). 
The primary hemostasis rate was also significantly lower 
with the TriClip (94% vs 76%, P = 0.01)[15].
Meanwhile the company has improved the clip model 
and offers a clip with two branches. It is called “instinct 
clip”, opens at a very wide angle, can be rotated and 
reopened. However it is a single use clip, requiring a 
complete application set for each application. So far 
there are no published clinical trials. However, an ex vivo 
study showed a good application even in full inversion of 
the endoscope and a durable tissue closure (Figure 5)[16].
The mechanical hemostasis is the only endoscopic 
procedure that offers a safe and permanent closure 
of larger vessels[17]. However, the exact placement on 
the bleeding source and the durability of the clip until 
hemostasis has occurred are important.
Figure 1  Hemospray (Cook Medical, Ireland) with a CO2 pressurized handle the mineral powder is applied with a catheter introduced through the working 
channel of the endoscope.
Figure 2  Over the scope clip (Oversco, Tübingen, Germany). The clip 
is preloaded on a transparent cap that can be fixed on the distal end of the 
endoscope. After suctioning of the bleeding source into the cap the clip is 
placed over the bleeding site.
Figure 3  Different types of through the scope clips. A: Quick clip, (Olympus, 
Hamburg, Deutschland); B: Instinct clip (Cook Medical, Limerick, Ireland); C: 
Resolution clip (Boston Scientific Germany, Ratingen, Germany).
A B C
Figure 4  Clip Master 3 (Medwork, Höchstadt/Aisch, Germany) is a through 
the scope clip with three consecutively preloaded clips. The clips can be 
applied without changing the device.
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Hepworth et al[18] compared the methods of endo­
scopic injection, heater probe thermal treatment, and 
clip application in an animal model on arterial vessels 
of different diameter. The injection could not achieve 
permanent hemostasis in any vessel diameter (1­3 
mm). But even with the state of the art hemostasis 
clips, the authors were only able to achieve permanent 
hemostasis in 10%­15% of the cases. The attempt to 
achieve a higher hemostasis rate with an endoscopic 
suture or an endoloop achieved more durable vascular 
occlusion. Another ex vivo study was performed on the 
“Erlangen Active Simulator for Interventional Endoscopy” 
and measured the closing pressure after endoscopic 
application of different clip models. The maximum closure 
pressure of 200 mmHg was achieved in 59% with the 
OTSC system. The resolution clip (Boston Scientific, 
Ratingen, Germany) accomplished this in 10%, quick 
clip (Olympus, Hamburg, Germany) 3% and in TriClip 
(Cook, Limerick, Irland) in 10%. With injection alone, the 
maximum occlusion pressure has been reached in 5% of 
the tests. The authors conclude from their experimental 
results that arterial vessels greater than 2 mm can only 
be closed with the OTSC System[19]. 
Another benefit of the OTSC System could be a 
circular grasp of the bleeding source and the surrounding 
tissue containing the supplying blood vessels. Kirschniak 
et al[20] reported the first clinical experience with the 
OTSC clip for hemostasis.
The clip was used for primary or postoperative 
bleeding in the gastrointestinal tract. In all seven patients 
in whom the clip was used for endoscopic hemostasis, 
the primary hemostasis was successful and there was no 
recurrent bleeding. Another series of 30 cases in which 
the conventional methods of endoscopic hemostasis had 
failed, use of the OTSC system achieved a success rate 
of 97% of primary hemostasis[21]. In two cases there was 
Clip Manufacturer Opening with Special
Clipmaster 3 Medwork, Höchstadt/Aisch, Germany 12 mm 3 clips in a row - no change of the applicator required
Quick clip 2 Olympus, Hamburg, Germany   9 mm Multiple use applicator 
Quick clip 2 long Olympus, Hamburg, Germany 11 mm Multiple use applicator
Resolution clip Boston Scientific, Ratingen, Germany 11 mm Reopenable after placement
Instinct clip Cook Medical, Limerick, Ireland 16 mm Reopenable after placement
Table 2  Currently available through the scope clips for endoscopic hemostasis
With the clipmaster 3 clips can be applied with one applicator. The quick clip applicator is a multiple use device but every clip has to be 
separately loaded. The instinct and the resolution clip can be closed and reopened until a proper position could be achieved.
A B C
D E F
Figure 5  Instinct clip. A: Forrest Ib ulcer in the prepyloric antrum; B: After injection of diluted epinephrine solution and clearing of the blood clot a small feeding 
vessel is identified; C: The instinct clip (Cook Medical, Ireland) is positioned close to the lesion and then the branches are rotated to the desired angle; D: The clip is 
placed at the basis of the ulcer; E: The clip is closed in a proper position; F: The clip is released and a second clip is positioned on the opposite position. 
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recurrent bleeding, which could be treated with repeated 
endoscopic treatment. In a recent case series, a technical 
success rate of 100% for hemostasis with the OTSC clip 
is reported. In two cases a rebleeding occurred, in one of 
which the source of bleeding was a multiply pretreated 
tumor[22].
HEMOSTASIS STATE OF THE ART - 
NONVARICEAL BLEEDING
In recent years, new techniques for endoscopic hemo­
stasis were introduced and known methods further 
improved.
With Hemospray and EndoClot two new compounds 
for topical treatment are available. Initial studies in this 
area have shown a good hemostatic effect, especially 
in active large scale oozing bleeding, e.g., tumor bleed­
ings. For further evaluation larger prospective studies 
comparing the substanced with other methods of endo­
scopic hemostasis are needed.
For localized active arterial bleeding, primary 
injection therapy in the area of  bleeding as well as in 
the four adjacent quadrants offers a good method to 
reduce bleeding activity. The injection is technically quite 
easy to learn and practicable. After bleeding activity is 
reduced the bleeding source can be localized more easily 
for clip application. Today many different TTS clips are 
available. The ability to close and reopen a clip can aid 
towards good positioning at the bleeding site. Even more 
important is the rotatability of a clip before application. 
Often multiple TTS clips are required for secure closure 
of a bleeding vessel. One model has the ability to use 
three clips in series without changing the applicator.
Severe arterial bleeding from vessels larger than 
2 mm is often unmanageable with these conventional 
methods. Here the OTSC system is a newly available 
method. Its mechanism is similar to the ligation of esoph­
ageal varices and involves aspiration of tissue into a 
transparent cap before closure of the clip. Thus a greater 
vascular occlusion pressure can be achieved and larger 
vessels can be treated endoscopically. Patients with 
severe arterial bleeding from the upper gastrointestinal 
tract have a very high rate of recurrence after initial 
endoscopic treatment. These patients should always be 
managed in an interdisciplinary team of interventional 
radiologist and surgeons.
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